CCS
NTUS

Crosspoint Capital Strategies’s Natus Medical Inc NTUS Stock Holding History

Crosspoint Capital Strategies’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-221
Closed -$8K – 883
2015
Q4 		$8K Buy
+221
New +$10.2K ﹤0.01% 736
2015
Q3 		– Sell
-246
Closed -$10K – 917
2015
Q2 		$10K Buy
+246
New +$9.8K ﹤0.01% 534
2015
Q1 		– Sell
-140
Closed -$5K – 781
2014
Q4 		$5K Buy
+140
New +$4.7K ﹤0.01% 611

Other funds holding NTUS

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Crosspoint Capital Strategies's NTUS Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Natus Medical Inc (NTUS) in Q1 2016, closing a stake of 221 shares — an estimated $8K sold.

Crosspoint Capital Strategies first reported a position in NTUS in Q4 2014 and held it in 3 quarters. The position peaked at $10K in Q2 2015. 207 funds tracked by Wall St. Rank hold NTUS as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Natus Medical Inc position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 221 Natus Medical Inc shares in Q1 2016, an estimated $8K.
  • Crosspoint Capital Strategies first reported a position in Natus Medical Inc in Q4 2014 and held it in 3 quarters.
  • Crosspoint Capital Strategies's Natus Medical Inc position peaked at $10K in Q2 2015.
  • 207 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.